SCHEMBL1899102

SCHEMBL1899102

CCCCC(CCCCC(=O)OCCO)CC(O)CO

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.52
DUSP3 P51452 1/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
LMNA P02545 1/20 0.52
CYP3A4 P08684 1/20 0.50
TSHR P16473 1/20 0.50
ATM Q13315 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
DGKA P23743 2/20 0.46
MGLL Q99685 1/20 0.45
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ENPP2 Q13822 4/20 0.41
FAAH O00519 2/20 0.41
TRPV1 Q8NER1 1/20 0.41
MAPT P10636 1/20 0.41
LPAR6 P43657 1/20 0.41
LPAR1 Q92633 1/20 0.41
LPAR4 Q99677 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1487853 0.93 KDM4E (0.55) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL1462388 0.93 KDM4E (0.51) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL1462396 0.86 DGKA (0.57) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL7128696 0.85 MGLL (0.65) DGKAMGLLALDH1A1ENPP2FAAH
SCHEMBL5473106 0.81 FFAR4 (0.46) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL16829870 0.81 DGKA (0.59) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL7203853 0.81 KDM4E (0.57) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL6052685 0.81 DGKA (0.62) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL16800412 0.81 DGKA (0.62) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL505106 0.81 DGKA (0.62) KDM4EDUSP3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110104085-A1 Cosmetic Or Pharmaceutical Compositions Comprising Modified Polysiloxanes With At Least One Carbamate Group CLARIANT FINANCE (BVI) LIMITED (VG) 2011-05-05 US disclosed
US-20050255075-A1 Cosmetic or pharmaceutical compositions comprising modified polyorganosiloxanes CLARIANT GMBH 2005-11-17 US disclosed
US-6607733-B1 Cosmetic or dermatological gels based on microemulsions BEIERSDORF AG (DE) 2003-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050255075-A1 Cosmetic or pharmaceutical compositions comprising modified polyorganosiloxanes POLH, SGMS2, SGMS1 KDM4E 1574/4885DUSP3 4703/4885MEN1 3844/4885
US-20110104085-A1 Cosmetic Or Pharmaceutical Compositions Comprising Modified Polysiloxanes With At Least One Carbamate Group KDM1A, KDM6A, KDM2A KDM4E 44/4885DUSP3 2994/4885MEN1 1211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.